Epidemiology of ovarian cancer: a review

Ovarian cancer (OC) is the seventh most commonly diagnosed cancer among women in the world and the tenth most common in China. Epithelial OC is the most predominant pathologic subtype, with five major histotypes that differ in origination, pathogenesis, molecular alterations, risk factors, and prognosis. Genetic susceptibility is manifested by rare inherited mutations with high to moderate penetrance. Genome-wide association studies have additionally identified 29 common susceptibility alleles for OC, including 14 subtype-specific alleles. Several reproductive and hormonal factors may lower risk, including parity, oral contraceptive use, and lactation, while others such as older age at menopause and hormone replacement therapy confer increased risks. These associations differ by histotype, especially for mucinous OC, likely reflecting differences in etiology. Endometrioid and clear cell OC share a similar, unique pattern of associations with increased risks among women with endometriosis and decreased risks associated with tubal ligation. OC risks associated with other gynecological conditions and procedures, such as hysterectomy, pelvic inflammatory disease, and polycystic ovarian syndrome, are less clear. Other possible risk factors include environmental and lifestyle factors such as asbestos and talc powder exposures, and cigarette smoking. The epidemiology provides clues on etiology, primary prevention, early detection, and possibly even therapeutic strategies.

[1]  V. Beral Ovarian cancer and hormone replacement therapy in the Million Women Study , 2007, The Lancet.

[2]  E. Vogtmann,et al.  Age at menarche and risk of ovarian cancer: A meta‐analysis of epidemiological studies , 2013, International journal of cancer.

[3]  B. Henderson,et al.  Reproductive, genetic, and dietary risk factors for ovarian cancer. , 1988, American journal of epidemiology.

[4]  Dana-Adriana Botesteanu Mathematical Models for Ovarian Cancer , 2017 .

[5]  B. Kupelnick,et al.  Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: a meta-analysis of 11,933 subjects from sixteen observational studies. , 2003, Anticancer research.

[6]  C. Bain,et al.  Alcohol, wine, and risk of epithelial ovarian cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  J. Stanford,et al.  Ovarian cancer incidence among Asian migrants to the United States and their descendants. , 1994, Journal of the National Cancer Institute.

[8]  S. Grénman,et al.  Cancer Risk in Women Using the Levonorgestrel-Releasing Intrauterine System in Finland , 2014, Obstetrics and gynecology.

[9]  D. Thomas,et al.  Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  O. Sheils,et al.  Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion , 2015, BMC Cancer.

[11]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[12]  K. Arga,et al.  Molecular signatures of ovarian diseases: Insights from network medicine perspective , 2016, Systems biology in reproductive medicine.

[13]  S. Kjaer,et al.  Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors , 2013, Cancer Causes & Control.

[14]  B. Modan,et al.  Cancer incidence in a cohort of infertile women. , 1987, American journal of epidemiology.

[15]  J. Buring,et al.  Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Incident Ovarian Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[16]  V. Siskind,et al.  Reproductive and other factors and risk of epithelial ovarian cancer: An australian case‐control study , 1995, International journal of cancer.

[17]  Charles E. Matthews,et al.  Physical Activity in Different Periods of Life, Sedentary Behavior, and the Risk of Ovarian Cancer in the NIH-AARP Diet and Health Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[18]  D. Thomas,et al.  High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. , 1992, European journal of cancer.

[19]  L. Kolonel,et al.  Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. , 2005, American journal of epidemiology.

[20]  Andy H. Lee,et al.  Sedentary behaviours and epithelial ovarian cancer risk , 2004, Cancer Causes & Control.

[21]  R. Ness,et al.  Alcohol Consumption and the Risk of Mucinous and Nonmucinous Epithelial Ovarian Cancer , 2003, Obstetrics and gynecology.

[22]  A. Russo,et al.  Hereditary ovarian cancer. , 2009, Critical reviews in oncology/hematology.

[23]  D. Machin Trends in Cancer Incidence and Mortality , 1995, British Journal of Cancer.

[24]  P. Hartge,et al.  Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort. , 2006, Journal of the National Cancer Institute.

[25]  Kathleen M. Fairfield,et al.  Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. , 2007, American journal of epidemiology.

[26]  L. Jones,et al.  Recreational physical activity and ovarian cancer risk and survival. , 2011, Annals of epidemiology.

[27]  N. Weiss,et al.  Incomplete pregnancies and risk of ovarian cancer (Washington, United States) , 1996, Cancer Causes & Control.

[28]  M. Cotterchio,et al.  Surgical procedures associated with risk of ovarian cancer. , 1997, International journal of epidemiology.

[29]  J. Monaghan,et al.  The epidemiology of ovarian cancer , 2001, International Journal of Gynecologic Cancer.

[30]  R. Gordon,et al.  Asbestos exposure and ovarian fiber burden. , 1996, American journal of industrial medicine.

[31]  L. Aaltonen,et al.  Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome , 1995, International journal of cancer.

[32]  P. Nasca,et al.  An epidemiologic case-control study of ovarian cancer and reproductive factors. , 1984, American journal of epidemiology.

[33]  S. Coughlin,et al.  A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer. , 2000, Journal of clinical epidemiology.

[34]  Sebastian M. Armasu,et al.  Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer , 2013, Nature Communications.

[35]  R. Goldbohm,et al.  Physical Activity and Risk of Ovarian Cancer: Results from the Netherlands Cohort Study (The Netherlands) , 2005, Cancer Causes & Control.

[36]  V. Beral,et al.  Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls , 2008, The Lancet.

[37]  I. Shih,et al.  TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high‐grade serous carcinoma—evidence supporting the clonal relationship of the two lesions , 2012, The Journal of pathology.

[38]  M. Thun,et al.  Tubal ligation and fatal ovarian cancer in a large prospective cohort study. , 1997, American journal of epidemiology.

[39]  F. Bray,et al.  Ovarian cancer in Europe: Cross‐sectional trends in incidence and mortality in 28 countries, 1953–2000 , 2005, International journal of cancer.

[40]  A. Godwin,et al.  Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management , 2009, Molecular oncology.

[41]  L. Sobin,et al.  Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. , 2003, American journal of epidemiology.

[42]  P. A. van den Brandt,et al.  Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  M. King,et al.  Mutation analysis of the BRCA1 gene in ovarian cancers. , 1995, Cancer research.

[44]  A. Uitterlinden,et al.  Genetics and biology of vitamin D receptor polymorphisms. , 2004, Gene.

[45]  D. Easton,et al.  Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer , 2000, International journal of cancer.

[46]  V. Beral,et al.  Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. , 2015, Lancet.

[47]  C. Carlson,et al.  Genetic Variation and Reproductive Timing: African American Women from the Population Architecture Using Genomics and Epidemiology (PAGE) Study , 2013, PloS one.

[48]  Ken R. Smith,et al.  Ovarian cancer mortality among immigrants in Australia and Canada. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[49]  M. Gwinn,et al.  Alcohol consumption and ovarian cancer risk. , 1986, American journal of epidemiology.

[50]  P. Hartge,et al.  A case-control study of epithelial ovarian cancer. , 1989, American journal of obstetrics and gynecology.

[51]  V. Beral,et al.  Risk factors for ovarian cancer: a case-control study. , 1989, British Journal of Cancer.

[52]  V. Beral,et al.  Pooled analysis of 3 european case‐control studies of ovarian cancer: II. Age at menarche and at menopause , 1991, International journal of cancer.

[53]  M. Pike,et al.  Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. , 2013, Endocrine-related cancer.

[54]  D. Thomas,et al.  Lactation and the risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. , 1993, International journal of epidemiology.

[55]  A. Folsom,et al.  Estrogen Replacement Therapy and Ovarian Cancer , 2004, Epidemiology.

[56]  M. Cotterchio,et al.  Association between frequency and intensity of recreational physical activity and epithelial ovarian cancer risk by age period , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[57]  Bin Wang,et al.  Hormone replacement therapy and ovarian cancer risk: a meta-analysis. , 2008, Gynecologic oncology.

[58]  J. Cerhan,et al.  Association of folate and alcohol with risk of ovarian cancer in a prospective study of postmenopausal women , 2004, Cancer Causes & Control.

[59]  Kconfab Investigators,et al.  Identification of six new susceptibility loci for invasive epithelial ovarian cancer , 2015 .

[60]  K. Robien,et al.  Tea Consumption and Epithelial Ovarian Cancer Risk: A Systematic Review of Observational Studies , 2011, Nutrition and cancer.

[61]  X. Shu,et al.  Population-based case-control study of ovarian cancer in Shanghai. , 1989, Cancer research.

[62]  Gordon B Mills,et al.  Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon , 2005, Clinical Cancer Research.

[63]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[64]  V. Cogliano International Agency for Research on Cancer (IARC) , 2018, The Grants Register 2019.

[65]  H. Grönberg,et al.  Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors. , 2011, Gynecologic oncology.

[66]  H. Risch,et al.  Parity, contraception, infertility, and the risk of epithelial ovarian cancer. , 1994, American journal of epidemiology.

[67]  S. Larsson,et al.  Wine consumption and epithelial ovarian cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[68]  F. Camacho,et al.  Analgesic medication use and risk of epithelial ovarian cancer in African American women , 2016, British Journal of Cancer.

[69]  D. English,et al.  Physical activity, body size and composition, and risk of ovarian cancer , 2010, Cancer Causes & Control.

[70]  M. Newhouse,et al.  A case control study of carcinoma of the ovary. , 1977, British journal of preventive & social medicine.

[71]  C. la Vecchia,et al.  Risk factors for epithelial ovarian cancer in Italy. , 1982, American journal of epidemiology.

[72]  Susan Halabi,et al.  Cyclin E Overexpression in Epithelial Ovarian Cancer Characterizes an Etiologic Subgroup , 2008, Cancer Epidemiology Biomarkers & Prevention.

[73]  H. Howe,et al.  Pathology and classification of ovarian tumors , 2003, Cancer.

[74]  X. Shu,et al.  Occupational physical activity and the incidence of cancer of the breast, corpus uteri, and ovary in shanghai , 1993, Cancer.

[75]  Lara E Sucheston-Campbell,et al.  Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[76]  M. Sowers,et al.  Effects of smoking on the development of female reproductive cancers. , 1984, Journal of the National Cancer Institute.

[77]  S. Pan,et al.  Physical activity and the risk of ovarian cancer: A case‐control study in Canada , 2005, International journal of cancer.

[78]  S. Hankinson,et al.  Perineal use of talc and risk of ovarian cancer , 2008, Journal of Epidemiology & Community Health.

[79]  Yan-Hong Huang,et al.  Association between alcohol consumption and the risk of ovarian cancer: a meta-analysis of prospective observational studies , 2015, BMC Public Health.

[80]  H. Xing,et al.  Aspirin inhibits growth of ovarian cancer by upregulating caspase-3 and downregulating bcl-2 , 2016, Oncology letters.

[81]  L. Brinton,et al.  Prospective study of physical activity and the risk of ovarian cancer , 2009, Cancer Causes & Control.

[82]  M. Goodman,et al.  Alcohol Consumption and the Risk of Borderline and Invasive Ovarian Cancer , 2003, Obstetrics and gynecology.

[83]  V. Beral,et al.  Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies , 2015, The Lancet.

[84]  A. Whittemore,et al.  Histologic types of epithelial ovarian cancer: have they different risk factors? , 2005, Gynecologic oncology.

[85]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[86]  M. Pike,et al.  Oral contraceptives and ovarian cancer. , 1983, The New England journal of medicine.

[87]  C. la Vecchia,et al.  Physical activity and risk of ovarian cancer: An Italian case‐control study , 2001, International journal of cancer.

[88]  P. Hartge,et al.  Menopause and ovarian cancer. , 1988, American journal of epidemiology.

[89]  Alcohol , 1984, Peptides.

[90]  W. McCluggage,et al.  Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. , 2011, Pathology.

[91]  C. la Vecchia,et al.  Incomplete pregnancies and ovarian cancer risk. , 1992, Gynecologic oncology.

[92]  M. Gultekin,et al.  Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers , 2004, Acta obstetricia et gynecologica Scandinavica.

[93]  C. Jackson,et al.  Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents , 2014, International journal of epidemiology.

[94]  C. la Vecchia,et al.  Fertility drugs and risk of epithelial ovarian cancer in Italy. , 1994, Human reproduction.

[95]  A. Whittemore,et al.  Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. , 2016, American journal of epidemiology.

[96]  D. Cramer,et al.  Evidence of Differential Effects of Vitamin D Receptor Variants on Epithelial Ovarian Cancer Risk by Predicted Vitamin D Status , 2014, Front. Oncol..

[97]  K. Kerlikowske,et al.  HORMONE REPLACEMENT THERAPY AND THE RISK OF EPITHELIAL OVARIAN CARCINOMA: A META‐ANALYSIS , 1998, Obstetrics and gynecology.

[98]  H. Brenner,et al.  Meta-analysis: Circulating vitamin D and ovarian cancer risk. , 2011, Gynecologic oncology.

[99]  M. Pike,et al.  Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies , 2012, The Lancet. Oncology.

[100]  M. Pike,et al.  Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin , 2009, Cancer.

[101]  Hereditary nonpolyposis colorectal cancer (Lynch syndrome): An updated review , 1996, Cancer.

[102]  Yashuang Zhao,et al.  Breastfeeding and ovarian cancer risk: a systematic review and meta-analysis of 40 epidemiological studies. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[103]  L. Schouten,et al.  Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls , 2009 .

[104]  W. Willett,et al.  Tubal Ligation, Hysterectomy, and Risk of Ovarian Cancer: A Prospective Study , 1993 .

[105]  E. Weiderpass,et al.  Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort. , 2011, International journal of oncology.

[106]  M. Janicek,et al.  Ovarian carcinoma: A review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer prevention , 1994 .

[107]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group. , 1993, Journal of the National Cancer Institute.

[108]  C. Bain,et al.  Tea consumption and risk of ovarian cancer , 2010, Cancer Causes & Control.

[109]  D. Trump,et al.  Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.

[110]  J. Kelsey,et al.  An epidemiologic study of epithelial carcinoma of the ovary. , 1981, American journal of epidemiology.

[111]  K. Moysich,et al.  Consumption of black tea or coffee and risk of ovarian cancer , 2006, International Journal of Gynecologic Cancer.

[112]  C. la Vecchia,et al.  Age at first birth and the risk of epithelial ovarian cancer. , 1984, Journal of the National Cancer Institute.

[113]  W. Su,et al.  Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. , 2011, The Lancet. Oncology.

[114]  J. Doherty,et al.  Breast-feeding and risk of epithelial ovarian cancer , 2012, Cancer Causes & Control.

[115]  C. la Vecchia,et al.  Global trends and predictions in ovarian cancer mortality. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[116]  D. Apter,et al.  Life‐long physical activity and cancer risk among Finnish female teachers , 1993, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[117]  Hui Xu,et al.  The VDR gene FokI polymorphism and ovarian cancer risk , 2013, Tumor Biology.

[118]  R. Crawford,et al.  Endometriosis and Ovarian Cancer: A Systematic Review , 2011, ISRN obstetrics and gynecology.

[119]  J. Stanford,et al.  Epithelial ovarian cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. , 1989, International journal of epidemiology.

[120]  I. Gram,et al.  Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition , 2011, British Journal of Cancer.

[121]  C. la Vecchia Oral contraceptives and ovarian cancer: an update, 1998–2004 , 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[122]  Y. Lee,et al.  Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis , 2013, Immunological investigations.

[123]  V. Beral,et al.  Pooled analysis of 3 european case‐control studies of epithelial ovarian cancer: III. Oral contraceptive use , 1991, International journal of cancer.

[124]  J. Muscat,et al.  Perineal talc use and ovarian cancer: a critical review , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[125]  Yurii B. Shvetsov,et al.  Genome-wide significant risk associations for mucinous ovarian carcinoma , 2015, Nature Genetics.

[126]  Brooke L. Fridley,et al.  GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer , 2013, Nature Genetics.

[127]  D. Easton,et al.  Contribution of BRCA1 mutations to ovarian cancer. , 1997, The New England journal of medicine.

[128]  S. Kjaer,et al.  Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study. , 2016, Gynecologic oncology.

[129]  Yurii B. Shvetsov,et al.  Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. , 2016, International journal of epidemiology.

[130]  Cuntong Wang Trends in contraceptive use and determinants of choice in China: 1980-2010. , 2012, Contraception.

[131]  Shui Wang,et al.  Meta‐analysis on the association between non‐steroidal anti‐inflammatory drug use and ovarian cancer , 2013, British journal of clinical pharmacology.

[132]  Helena Carreira,et al.  Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) , 2015, The Lancet.

[133]  A. Ziogas,et al.  Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer. , 2000, European journal of cancer.

[134]  R. Mathur,et al.  The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. , 1985, Maturitas.

[135]  H. Risch Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. , 1999, Journal of the National Cancer Institute.

[136]  Kurt Straif,et al.  Carcinogenicity of carbon black, titanium dioxide, and talc. , 2006, The Lancet Oncology.

[137]  C. la Vecchia Epidemiology of ovarian cancer: a summary review , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[138]  L. Petersen,et al.  Physical activity in leisure-time and risk of cancer: 14-year follow-up of 28,000 Danish men and women , 2005, Scandinavian journal of public health.

[139]  P. Dickman,et al.  Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women , 2004, European Journal of Epidemiology.

[140]  M. Goodman,et al.  Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. , 2002, American journal of epidemiology.

[141]  P. Wingo,et al.  The reduction in risk of ovarian cancer associated with oral-contraceptive use. , 1987, The New England journal of medicine.

[142]  A. Whittemore,et al.  Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. , 1988, American journal of epidemiology.

[143]  T. Sellers,et al.  Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer , 2012, British Journal of Cancer.

[144]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[145]  Wei Lu,et al.  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer , 2013, Nature Genetics.

[146]  A. Wolk,et al.  Red and processed meat consumption and risk of ovarian cancer: a dose-response meta-analysis of prospective studies , 2011, British Journal of Cancer.

[147]  A. Good Estrogens and Progestogens in Clinical Practice , 1999 .

[148]  S. Shapiro,et al.  A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. , 1994, American journal of epidemiology.

[149]  Wanqing Chen,et al.  Ovary cancer incidence and mortality in China, 2011. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[150]  A. Berchuck,et al.  Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States) , 2002, Cancer Causes & Control.

[151]  D. Whiteman,et al.  Does smoking increase risk of ovarian cancer? A systematic review. , 2006, Gynecologic Oncology.

[152]  R. Goldbohm,et al.  Consumption of dietary fat and meat and risk of ovarian cancer in the Netherlands Cohort Study. , 2011, The American journal of clinical nutrition.

[153]  S. Nilsson,et al.  Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies , 2004, Acta obstetricia et gynecologica Scandinavica.

[154]  Jacques Ferlay,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .

[155]  B. Rosen,et al.  Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. , 2001, American journal of human genetics.

[156]  R. Ness,et al.  Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. , 2011, Annals of epidemiology.

[157]  H. Martha,et al.  Endometriosis , 2015 .

[158]  C. la Vecchia,et al.  Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer. , 2005, Gynecologic oncology.

[159]  Xiaocheng Wu,et al.  Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations , 2006, Cancer.

[160]  C. la Vecchia,et al.  Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012. , 2012, Alcohol and alcoholism.

[161]  R. Berkowitz,et al.  Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship , 2007, The American journal of surgical pathology.

[162]  P. Ridker,et al.  Genome-wide association studies identify novel loci associated with age at menarche and age at natural menopause , 2009, Nature Genetics.

[163]  J. Klijn,et al.  Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers , 2004, Clinical Cancer Research.

[164]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[165]  S. Nilsson,et al.  Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence , 1998, Clinical endocrinology.

[166]  P. Hartge,et al.  Risk factors in ovarian cancer. , 1988, European journal of gynaecological oncology.

[167]  I. Shih,et al.  Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary: Distinctive Tumors That Differ in Their Pathogenesis and Behavior: A Clinicopathologic Analysis of 122 Cases , 2009, The American journal of surgical pathology.

[168]  J. Prat Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features , 2012, Virchows Archiv.

[169]  H. Langseth,et al.  Asbestos fibers in ovarian tissue from Norwegian pulp and paper workers , 2006, International Journal of Gynecologic Cancer.

[170]  A. Whittemore,et al.  Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. , 2016, International journal of epidemiology.

[171]  D. Cramer,et al.  Determinants of ovarian cancer risk. I. Reproductive experiences and family history. , 1983, Journal of the National Cancer Institute.

[172]  C. Bain,et al.  Meat, fish, and ovarian cancer risk: Results from 2 Australian case-control studies, a systematic review, and meta-analysis. , 2010, The American journal of clinical nutrition.

[173]  Å. Borg,et al.  One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. , 2004, European journal of cancer.

[174]  K. Hemminki,et al.  Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer? , 2011, European journal of cancer.

[175]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[176]  D. Cramer,et al.  Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. , 1983, Journal of the National Cancer Institute.

[177]  V. Siskind,et al.  Incomplete pregnancy and risk of ovarian cancer: results from two Australian case–control studies and systematic review , 2009, Cancer Causes & Control.

[178]  Setsuko K Chambers,et al.  Tubal origin of ovarian low-grade serous carcinoma. , 2013, American journal of clinical and experimental obstetrics and gynecology.

[179]  P. V. van Diest,et al.  Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer , 2001, The Journal of pathology.

[180]  J. Onwude Hormone therapy and ovarian cancer , 2015, The Lancet.

[181]  L. Zelek,et al.  Prospective association between alcohol intake and hormone-dependent cancer risk: modulation by dietary fiber intake. , 2015, The American journal of clinical nutrition.

[182]  B. Rosner,et al.  Risk factors for epithelial ovarian cancer by histologic subtype. , 2010, American journal of epidemiology.

[183]  Robert C. Lee,et al.  A systematic literature review of vitamin D and ovarian cancer. , 2010, American journal of obstetrics and gynecology.

[184]  M. Morgan,et al.  Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives , 2001 .

[185]  C. Friedenreich,et al.  Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition , 2009, International journal of cancer.

[186]  P. Vercellini,et al.  Bias versus causality: interpreting recent evidence of association between endometriosis and ovarian cancer. , 2007, Fertility and sterility.

[187]  T. Oury,et al.  Experimental Models of Asbestos-Related Diseases , 2014 .

[188]  Esther Cheng,et al.  Robbins Basic Pathology. , 2017, American journal of clinical pathology.

[189]  A. Berchuck,et al.  Ovarian cancer risk factors in African-American and white women. , 2009, American journal of epidemiology.

[190]  M. Rossing,et al.  Analgesic drug use and risk of epithelial ovarian cancer. , 2008, American journal of epidemiology.

[191]  W. O'Fallon,et al.  Ovarian cancer. Incidence and case‐control study , 1979, Cancer.

[192]  C. la Vecchia,et al.  Risk factors for ovarian cancer histotypes. , 2007, European journal of cancer.

[193]  Ming Wu,et al.  Increase of Incidence and Mortality of Ovarian Cancer during 2003–2012 in Jiangsu Province, China , 2016, Front. Public Health.

[194]  A. Sood,et al.  Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer , 2016, Molecular Cancer Therapeutics.

[195]  M. Thun,et al.  Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[196]  Andy H. Lee,et al.  Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies , 2012, The Lancet. Oncology.

[197]  F. Clavel-Chapelon,et al.  Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition , 2006, Cancer Causes & Control.

[198]  B. Rosner,et al.  Surrogates of Long-Term Vitamin D Exposure and Ovarian Cancer Risk in Two Prospective Cohort Studies , 2013, Cancers.

[199]  D. Trichopoulos,et al.  Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer , 1993, International journal of cancer.

[200]  M. Thun,et al.  Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen , 2010, International journal of cancer.

[201]  L. Aaltonen,et al.  Cancer risk in mutation carriers of DNA‐mismatch‐repair genes , 1999, International journal of cancer.

[202]  Hongbing Shen,et al.  Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women , 2022 .

[203]  A. Berchuck,et al.  Analgesic Drug Use and Risk of Ovarian Cancer , 2006, Epidemiology.

[204]  A. Folsom,et al.  Anthropometric variables, physical activity, and incidence of ovarian cancer , 2004, Cancer.

[205]  C. Friedenreich,et al.  Physical Activity and Ovarian Cancer Risk: the European Prospective Investigation into Cancer and Nutrition , 2009, Cancer Epidemiology Biomarkers & Prevention.

[206]  N. Le,et al.  Adult lifetime alcohol consumption and invasive epithelial ovarian cancer risk in a population-based case-control study. , 2016, Gynecologic oncology.

[207]  B. Rosner,et al.  American Journal of Epidemiology Original Contribution Use of Nonsteroidal Antiinflammatory Agents and Incidence of Ovarian Cancer in 2 Large Prospective Cohorts , 2022 .

[208]  K. Yoo,et al.  Menstrual factors and cancer risk among Korean women. , 2011, International journal of epidemiology.

[209]  Donghui Li Metformin as an antitumor agent in cancer prevention and treatment , 2011, Journal of diabetes.

[210]  J. Ferlay,et al.  Worldwide burden of gynaecological cancer: the size of the problem. , 2006, Best practice & research. Clinical obstetrics & gynaecology.

[211]  L. Titus,et al.  Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. , 2013, Human reproduction.

[212]  J. Chang-Claude,et al.  Physical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. , 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[213]  A. Kriska,et al.  Physical Activity and Reduced Risk of Ovarian Cancer , 2000, Obstetrics and gynecology.

[214]  X. Shu,et al.  Contraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai Women's Health Study , 2015, International Journal of Cancer.

[215]  A. Folsom,et al.  Nonsteroidal Anti-Inflammatory Drugs and Risk for Ovarian and Endometrial Cancers in the Iowa Women's Health Study , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[216]  V. Siskind,et al.  Breastfeeding and risk of epithelial ovarian cancer , 2009, Cancer Causes & Control.

[217]  H. Risch,et al.  Pelvic inflammatory disease and the risk of epithelial ovarian cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[218]  C. Bain,et al.  Recreational Physical Activity and Epithelial Ovarian Cancer: A Case-Control Study, Systematic Review, and Meta-analysis , 2007, Cancer Epidemiology Biomarkers & Prevention.

[219]  M. Thun,et al.  Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women. , 2006, American journal of epidemiology.

[220]  Yurii B. Shvetsov,et al.  Identification of six new susceptibility loci for invasive epithelial ovarian cancer , 2015, Nature Genetics.

[221]  R. Hayes,et al.  Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey , 1993, Cancer Causes & Control.

[222]  S. Lowry,et al.  Incessant ovulation and ovarian cancer , 1991, The Lancet.

[223]  D. Cramer,et al.  Cigarette Smoking and Epithelial Ovarian Cancer by Histologic Type , 2000, Obstetrics and gynecology.

[224]  M. Quinn,et al.  Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer , 1997, International journal of cancer.

[225]  M. Thun,et al.  Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. , 2001, JAMA.

[226]  C. la Vecchia,et al.  Alcohol drinking and epithelial ovarian cancer risk. a systematic review and meta-analysis. , 2012, Gynecologic oncology.

[227]  Andy H. Lee,et al.  Physical activity and epithelial ovarian cancer risk: A case‐control study in China , 2003, International journal of cancer.

[228]  S. Shapiro,et al.  Noncontraceptive estrogen use and epithelial ovarian cancer. , 1989, American journal of epidemiology.

[229]  R. Hayes,et al.  Circulating 25-Hydroxyvitamin D and Risk of Epithelial Ovarian Cancer , 2010, American journal of epidemiology.

[230]  F. Camacho,et al.  Recreational physical activity and ovarian cancer risk in African American women , 2016, Cancer medicine.

[231]  A. Jensen,et al.  Use of analgesic drugs and risk of ovarian cancer: results from a Danish case–control study , 2012, Acta obstetricia et gynecologica Scandinavica.

[232]  V. Beral,et al.  Pooled analysis of 3 european case‐control studies: I. Reproductive factors and risk of epithelial ovarian cancer , 1991, International journal of cancer.

[233]  W. Aronow,et al.  Prevalence and Causes of Persistent Use of Hormone Replacement Therapy Among Postmenopausal Women: A Follow-Up Study , 2006, American journal of therapeutics.

[234]  R. Goldbohm,et al.  Alcohol and ovarian cancer risk: results from the Netherlands Cohort Study , 2004, Cancer Causes & Control.

[235]  J. Schildkraut,et al.  Epithelial Ovarian Cancer Risk Among Women With Polycystic Ovary Syndrome , 1996, Obstetrics and gynecology.

[236]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[237]  S. Kjaer,et al.  Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. , 1997, Fertility and sterility.

[238]  W. Chung,et al.  Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk , 2013, PLoS genetics.

[239]  Lara E Sucheston-Campbell,et al.  Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[240]  M. Pike,et al.  Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. , 2014, Journal of the National Cancer Institute.

[241]  R. Hayes,et al.  Circulating 25-Hydroxyvitamin D and Risk of Pancreatic Cancer , 2010, American journal of epidemiology.

[242]  S. Kjær,et al.  Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case–control study , 2015, Acta obstetricia et gynecologica Scandinavica.

[243]  E. Funkhouser,et al.  Reproductive factors and ovarian cancer risk in African-American women. , 2016, Annals of epidemiology.

[244]  Russell Vang,et al.  Fallopian tube precursors of ovarian low‐ and high‐grade serous neoplasms , 2013, Histopathology.

[245]  P. Hartge,et al.  Risk factors for epithelial ovarian cancer in Beijing, China. , 1992, International journal of epidemiology.

[246]  T. Rebbeck,et al.  Prophylactic oophorectomy in women at increased cancer risk , 2007, Current opinion in obstetrics & gynecology.

[247]  T. VanderWeele,et al.  Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine , 2016, Epidemiology.

[248]  Andy H. Lee,et al.  Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies , 2012, PLoS medicine.

[249]  W. Willett,et al.  A prospective study of reproductive factors and risk of epithelial ovarian cancer , 1995, Cancer.

[250]  L. Titus,et al.  Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case–Control Study , 2013, International journal of cancer.

[251]  M. King,et al.  Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary , 2000, International journal of cancer.

[252]  Enrico Carmina,et al.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. , 2012, Fertility and sterility.

[253]  D. Cramer,et al.  Incessant Ovulation, Mucin 1 Immunity, and Risk for Ovarian Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[254]  Valerie Beral,et al.  ORAL CONTRACEPTIVE USE AND MALIGNANCIES OF THE GENITAL TRACT Results from The Royal College of General Practitioners' Oral Contraception Study , 1988, The Lancet.

[255]  J. Kotsopoulos,et al.  Anthropometric Measures and Risk of Epithelial Ovarian Cancer: Results From the Nurses' Health Study , 2010, Obesity.

[256]  N. Day,et al.  The epidemiology of ovarian cancer in Greece: a case-control study. , 1984, European journal of cancer & clinical oncology.

[257]  A. Whittemore,et al.  A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 , 2010, Nature Genetics.

[258]  S. E. Dietert,et al.  Noncontraceptive estrogen use and the occurrence of ovarian cancer. , 1982, Journal of the National Cancer Institute.

[259]  R. Ness,et al.  Cigarette Smoking and the Risk of Mucinous and Nonmucinous Epithelial Ovarian Cancer , 2002, Epidemiology.

[260]  L. Bernstein,et al.  Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort , 2010, Cancer Causes & Control.

[261]  A. Chetrit,et al.  Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. , 1999, Fertility and sterility.

[262]  L. Arab Epidemiologic Evidence on Coffee and Cancer , 2010, Nutrition and cancer.

[263]  C. Wahlberg Tubal ligation, hysterectomy, and risk of ovarian cancer. , 1994, JAMA.

[264]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[265]  J. Shelton,et al.  Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections. , 1983, Journal of the American Medical Association (JAMA).

[266]  S. Franceschi,et al.  Oral Contraceptives and Cancer , 2001, Drug safety.

[267]  N. Weiss,et al.  Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer? , 1986, American journal of epidemiology.

[268]  H. Xing,et al.  Aspirin inhibits growth of ovarian cancer by upregulating caspase-3 and downregulating bcl-2 , 2016, Oncology letters.

[269]  A. Whittemore,et al.  A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 , 2009, Nature Genetics.

[270]  N. Weiss,et al.  Recreational physical activity and risk of epithelial ovarian cancer , 2010, Cancer Causes & Control.

[271]  Age at menarche and age at natural menopause in East Asian women: a genome-wide association study , 2016, AGE.

[272]  E. Greiser,et al.  Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis. , 2007, Human reproduction update.

[273]  H. Adami,et al.  Parity, age at first childbirth, and risk of ovarian cancer , 1994, The Lancet.

[274]  W. Willett,et al.  Prospective study of recreational physical activity and ovarian cancer. , 2001, Journal of the National Cancer Institute.

[275]  J. Olsen,et al.  Relationship of Benign Gynecologic Diseases to Subsequent Risk of Ovarian and Uterine Tumors , 2005, Cancer Epidemiology Biomarkers & Prevention.

[276]  H. Adami,et al.  Prospective study of physical activity in different periods of life and the risk of ovarian cancer , 2006, International journal of cancer.

[277]  A. McTiernan,et al.  Mechanisms linking physical activity with cancer , 2008, Nature Reviews Cancer.

[278]  B. Rosner,et al.  Talc Use, Variants of the GSTM1, GSTT1, and NAT2 Genes, and Risk of Epithelial Ovarian Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[279]  S. Self,et al.  Ovarian tumors in a cohort of infertile women. , 1994, The New England journal of medicine.

[280]  C. la Vecchia,et al.  Pelvic inflammatory disease and risk of ovarian cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[281]  C. la Vecchia,et al.  Risk factors for epithelial ovarian cancer in women under age 45. , 1993, European journal of cancer.

[282]  J. Olsen,et al.  Low-dose aspirin use and the risk of ovarian cancer in Denmark. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[283]  M. Piver,et al.  Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. , 1999, Gynecologic oncology.

[284]  J. Kendrick,et al.  Cigarette smoking and the risk of epithelial ovarian cancer. , 1987, American journal of epidemiology.

[285]  D. Seminara,et al.  Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[286]  Reproductive factors, adiposity, breastfeeding and their associations with ovarian cancer in an Asian cohort , 2015, Cancer Causes & Control.

[287]  I. Gram,et al.  Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition , 2011, Cancer Causes & Control.

[288]  I. Shih,et al.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. , 2004, The American journal of pathology.

[289]  I. Gram,et al.  An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study , 2015, British Journal of Cancer.

[290]  S. Gapstur,et al.  Moderate-to-vigorous physical activity and leisure-time sitting in relation to ovarian cancer risk in a large prospective US cohort , 2015, Cancer Causes and Control.

[291]  D. Easton,et al.  A systematic review and meta‐analysis of family history and risk of ovarian cancer , 1998, British journal of obstetrics and gynaecology.

[292]  E. Hovig,et al.  BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study , 2004, British Journal of Cancer.

[293]  D. Albanes,et al.  Physical activity and risk of ovarian cancer: a prospective cohort study in the United States. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[294]  C. la Vecchia,et al.  Risk factors for different histological types of ovarian cancer , 2003, International Journal of Gynecologic Cancer.

[295]  R. Goldbohm,et al.  Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies , 2006, British Journal of Cancer.

[296]  A. Trentham-Dietz,et al.  Alcohol consumption and ovarian cancer risk in a population‐based case–control study , 2006, International journal of cancer.

[297]  V. Beral,et al.  Reproductive factors and risk of ovarian cancer: A prospective study , 1988, International journal of cancer.

[298]  S. Hankinson,et al.  A prospective study of leisure‐time physical activity and risk of incident epithelial ovarian cancer: Impact by menopausal status , 2016, International journal of cancer.

[299]  Laetitia Huiart,et al.  Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. , 2011, JAMA.

[300]  A. Green,et al.  Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer , 2008, International journal of cancer.

[301]  G. Colditz,et al.  Mathematical Models of Ovarian Cancer Incidence , 2005, Epidemiology.

[302]  P. Hartge,et al.  Risk Prediction for Breast, Endometrial, and Ovarian Cancer in White Women Aged 50 y or Older: Derivation and Validation from Population-Based Cohort Studies , 2013, PLoS medicine.

[303]  Jeong-Won Lee,et al.  Histologic distribution of borderline ovarian tumors worldwide: a systematic review , 2013, Journal of gynecologic oncology.

[304]  S. Jick,et al.  Use of metformin and the risk of ovarian cancer: a case-control analysis. , 2011, Gynecologic oncology.

[305]  Hui Xu,et al.  Vitamin D receptor rs2228570 polymorphism and susceptibly to ovarian cancer: a meta-analysis , 2014, Tumor Biology.

[306]  R. Langer,et al.  Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. , 2003, JAMA.

[307]  R. Goldbohm,et al.  Reproductive and Hormonal Factors in Association With Ovarian Cancer in the Netherlands Cohort Study , 2010, American journal of epidemiology.

[308]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[309]  A. Venn,et al.  Breast and ovarian cancer incidence after infertility and in vitro fertilisation , 1995, The Lancet.

[310]  F. Clavel-Chapelon,et al.  Reproductive and hormone‐related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort , 2015, International journal of cancer.

[311]  D. Whiteman,et al.  Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. , 2007, European journal of cancer.

[312]  A. Whittemore,et al.  Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31 , 2013, Nature Communications.

[313]  H. Risch Estrogen replacement therapy and risk of epithelial ovarian cancer. , 1996, Gynecologic oncology.

[314]  K. Oktay,et al.  Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[315]  Menopausal hormone replacement therapy and risk of ovarian cancer , 2002, JAMA.

[316]  N. Weiss,et al.  Menopausal Hormone Therapy and Risk of Epithelial Ovarian Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[317]  G. Colditz,et al.  A prospective study of postmenopausal hormone use and ovarian cancer risk , 2006, British Journal of Cancer.

[318]  A. Whittemore,et al.  Assessing the genetic architecture of epithelial ovarian cancer histological subtypes , 2016, Human Genetics.

[319]  P. Newcomb,et al.  Cigarette smoking in relation to risk of large bowel cancer in women. , 1995, Cancer research.

[320]  J. Seidman,et al.  Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors. , 2008, Archives of pathology & laboratory medicine.

[321]  C. la Vecchia,et al.  Family history of reproductive cancers and ovarian cancer risk: an Italian case-control study. , 1992, American journal of epidemiology.

[322]  M. Widschwendter,et al.  Tubal ligation and the risk of ovarian cancer: review and meta-analysis. , 2011, Human reproduction update.

[323]  C. la Vecchia,et al.  Family history of cancer and risk of ovarian cancer. , 2003, European journal of cancer.

[324]  A. Jakubowska,et al.  Hereditary ovarian cancer in Poland. , 2004, International journal of cancer.

[325]  Peter Kraft,et al.  Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. , 2016, Cancer discovery.

[326]  L. Brinton,et al.  Body mass index and risk of ovarian cancer , 2009, Cancer.

[327]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[328]  Ie-Ming Shih,et al.  The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory , 2010, The American journal of surgical pathology.

[329]  A. Whittemore,et al.  Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. , 2015, Human molecular genetics.

[330]  L. Yoder The epidemiology of ovarian cancer: a review. , 1990, Oncology nursing forum.

[331]  M. McCullough,et al.  Leisure-Time Spent Sitting and Site-Specific Cancer Incidence in a Large U.S. Cohort , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[332]  J. Krischer,et al.  BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases , 2005, Cancer.

[333]  Heiner Boeing,et al.  Dietary Determinants of Epithelial Ovarian Cancer: A Review of the Epidemiologic Literature , 2004, Nutrition and cancer.

[334]  H. Risch,et al.  Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. , 1996, American journal of epidemiology.

[335]  M. Vessey,et al.  Oral contraceptive use and cancer. Findings in a large cohort study, 1968–2004 , 2006, British Journal of Cancer.

[336]  N. de Klerk,et al.  Does Exposure to Asbestos Cause Ovarian Cancer? A Systematic Literature Review and Meta-analysis , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[337]  H. Chung,et al.  Wine drinking and epithelial ovarian cancer risk: a meta-analysis. , 2010, Journal of gynecologic oncology.

[338]  M. Gwinn,et al.  Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. , 1990, Journal of clinical epidemiology.

[339]  P. Dickman,et al.  Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. , 2002, American journal of epidemiology.

[340]  L. Holmberg,et al.  Alcoholism and cancer risk: a population-based cohort study , 1992, Cancer Causes & Control.

[341]  E. Wynder,et al.  Epidemiology of cancer of the ovary , 1969, Cancer.

[342]  C. la Vecchia,et al.  Menstrual factors and the risk of epithelial ovarian cancer. , 1989, Journal of clinical epidemiology.

[343]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[344]  A. Whittemore,et al.  Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. , 1988, American journal of epidemiology.

[345]  Richard J. K. Taylor,et al.  The impact of changes in hormone therapy on breast cancer incidence in the US population , 2009, Cancer Causes & Control.

[346]  G. Reeves,et al.  Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type , 2015, International journal of cancer.

[347]  S. Larsson,et al.  Coffee Consumption Is Not Associated with Ovarian Cancer Incidence , 2005, Cancer Epidemiology Biomarkers & Prevention.

[348]  A. Lilienfeld,et al.  An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. , 1974, American journal of epidemiology.

[349]  Orli G. Bahcall,et al.  iCOGS collection provides a collaborative model , 2013, Nature Genetics.

[350]  L. Titus,et al.  The Association Between Talc Use and Ovarian Cancer , 2016, Epidemiology.

[351]  P. Hartge,et al.  Ovarian cancer risk factors by histologic subtypes in the NIH‐AARP diet and health study , 2012, International journal of cancer.

[352]  S. Hankinson,et al.  Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies. , 2014, Fertility and sterility.

[353]  R. Goldbohm,et al.  Height, Body Mass Index, and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies , 2008, Cancer Epidemiology Biomarkers & Prevention.

[354]  D. Aoki,et al.  Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning. , 2016, Oncology letters.

[355]  L. Mcgowan Epidemiology of ovarian cancer. , 1989, Oncology.

[356]  Yu-qin Pan,et al.  Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk , 2014, Tumor Biology.

[357]  E. Weiderpass,et al.  Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. , 2002, Journal of the National Cancer Institute.

[358]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[359]  A. Whittemore,et al.  Common variants at 19p13 are associated with susceptibility to ovarian cancer , 2010, Nature Genetics.

[360]  W. Willett,et al.  Recreational physical activity and ovarian cancer in a population‐based case‐control study , 2002, International journal of cancer.